Intuitive Has Released Its Earnings for the Third Quarter

2 min read | October 18, 2024 03:53 AM PDT | By Team Kalkine Media

Highlights:

  • Procedure Growth: Worldwide da Vinci procedures increased by 18% year-over-year, indicating a rising adoption of robotic-assisted surgeries.

  • System Placements: The company placed 379 da Vinci surgical systems in Q3 2024, a significant increase from 312 systems in the same period last year.

  • Financial Performance: Revenue for the quarter rose by 17% to $2.04 billion, with GAAP net income reaching $565 million, translating to $1.56 per diluted share.

Intuitive Surgical's (NASDAQ:ISRG) Q3 2024 results reflect a strong upward trajectory in both procedure volume and system placements. The total number of da Vinci surgical systems installed globally increased by 15%, reaching an installed base of 9,539 systems. This expansion highlights the growing recognition and utilization of robotic-assisted surgical systems in various medical fields.

The revenue generated from instruments and accessories also demonstrated robust growth, rising by 18% year-over-year. This increase in revenue was complemented by a notable rise in systems revenue, further underscoring the company's market position and operational strength.

In terms of profitability, Intuitive Surgical reported a GAAP net income of $565 million, equivalent to $1.56 per diluted share. Non-GAAP net income was reported at $669 million, or $1.84 per diluted share. These figures illustrate the company’s ability to maintain strong profitability while scaling operations.

Intuitive Surgical concluded the quarter with an impressive cash and investment balance of $8.31 billion. This substantial financial position provides the company with ample resources for potential future growth opportunities, research and development initiatives, and operational enhancements.

Overall, the third quarter results highlight Intuitive Surgical's ongoing success in the healthcare sector, driven by increasing demand for innovative surgical solutions and a solid commitment to enhancing patient care through advanced technology.

 

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next